|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 38/08 |
| (11) | Number of the document | 2802347 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13736176.2 |
| Date of filing the European patent application | 2013-01-14 | |
| (97) | Date of publication of the European application | 2014-11-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/021448 |
| Date | 2013-01-14 |
| (87) | Number | WO 2013/106834 |
| Date | 2013-07-18 |
| (30) | Number | Date | Country code |
| 201261586177 P | 2012-01-13 | US | |
| 201261647207 P | 2012-05-15 | US |
| (72) |
O`REILLY, Richard, J., US
DOUBROVINA, Ekaterina, US
SELVAKUMAR, Annamalai, US
|
| (73) |
Memorial Sloan Kettering Cancer Center,
1275 York Avenue, New York, NY 10021,
US
|
| (54) | IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF |
| IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF |